Health Hazards in Females | How do we Increase Women in Interventional Cardiology?

Saturday, March 8, 2025

3:45 PM - 3:53 PM ET

Speaker(s)

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI

Professor of Cardiology and Population Health Science and Policy, Mount Sinai Endowed Professor in Cardiovascular Clinical Research and Outcomes; Director of Interventional Cardiovascular Research and Clinical Trials; Director of Women’s Heart and Vascular Center at Mount Sinai Heart
Icahn School of Medicine at Mount Sinai, New York
New York, New York, United States

Disclosure information not submitted.

Disclosure(s):

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI: Abbott, Alleviant Medical, Beth Israel Deaconess Medical Center, Concept Medical, Cordis, Elixir Medical, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Mediasphere Medical, Medtronic, Novartis, Protembis GmbH, Sanofi, RM Glo: Grant/Research Support (Ongoing); AMA - JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elixir Medical, Stel, ControlRad (spouse): Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Elixir Medical, IQVIA, Medtronic, Medscape/WebMD Global, NovoNordisk: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director): SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director) (Ongoing)